Published in Chest on July 01, 1983
Improvement of pressurised aerosol deposition with Nebuhaler spacer device. Thorax (1984) 3.30
Drug delivery from holding chambers with attached facemask. Arch Dis Child (1992) 2.72
Inhalational drug delivery from seven different spacer devices. Thorax (1996) 1.78
Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax (1991) 1.65
Therapeutic aerosols 1--physical and practical considerations. Thorax (1983) 1.36
Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol (2003) 1.27
Pressurised aerosol deposition in the human lung with and without an "open" spacer device. Thorax (1989) 1.17
Metered dose inhaler and nebuliser in acute asthma. Arch Dis Child (1995) 1.06
Respirable dose delivery of fluticasone propionate from a small valved holding chamber, a compact breath actuated integrated vortex device and a metered dose inhaler. Br J Clin Pharmacol (2008) 0.85
Early lung absorption profile of non-CFC salbutamol via small and large volume plastic spacer devices. Br J Clin Pharmacol (1998) 0.85
Comparison of two chamber devices in patients using a metered-dose inhaler with satisfactory technique. CMAJ (1986) 0.82
Clinical and functional responses to salbutamol inhaled via different devices in asthmatic patients with induced bronchoconstriction. Br J Clin Pharmacol (2004) 0.78
The rapid and effective administration of a beta 2-agonist to horses with heaves using a compact inhalation device and metered-dose inhalers. Can Vet J (1994) 0.77
The History of Therapeutic Aerosols: A Chronological Review. J Aerosol Med Pulm Drug Deliv (2016) 0.75
The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol (1990) 3.40
The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience. Ann Intern Med (1990) 2.89
Standardization of inhalation provocation tests: two techniques of aerosol generation and inhalation compared. Am Rev Respir Dis (1981) 2.75
Management of asthma and chronic airflow limitation. Are methylxanthines obsolete? Chest (1990) 2.67
Dosing efficiency and particle-size characteristics of pressurized metered-dose inhaler aerosols in narrow catheters. Chest (1993) 2.06
Aerosol salbutamol administration by IPPB: lowest effective dose. Thorax (1978) 2.05
Asthma therapy with aerosols: are nebulizers obsolete? A continuing controversy. J Pediatr (1999) 2.03
Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia. Am J Physiol Lung Cell Mol Physiol (2002) 1.92
Control of asthma by aerosols. N Engl J Med (1986) 1.89
Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life. Am Rev Respir Dis (1987) 1.85
Aerosol penetrance: a sensitive index of peripheral airways obstruction. J Appl Physiol (1976) 1.83
Restrictions on smoking at home and urinary cotinine levels among children with asthma. Am J Prev Med (2000) 1.81
Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue. Am Rev Respir Dis (1988) 1.68
Standardization of inhalation provocation tests: influence of nebulizer output, particle size, and method of inhalation. J Allergy Clin Immunol (1981) 1.66
Selectivity of beta adrenoreceptor antagonist drugs assessed by histamine bronchial provocation. Clin Pharmacol Ther (1979) 1.60
Asthma management in eastern Australia, 1990 and 1993. Med J Aust (1996) 1.59
Optimal delivery of aerosols from metered dose inhalers. Chest (1981) 1.59
Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients. Comparison of dose to the lungs. Am Rev Respir Dis (1990) 1.50
Risk factors for repeat attendance at hospital emergency departments among adults and children with asthma. Aust N Z J Med (1997) 1.48
The effects of preferential deposition of histamine in the human airway. Am Rev Respir Dis (1978) 1.48
Relationship between acute respiratory illness and air pollution levels in an industrial city. Am Rev Respir Dis (1977) 1.46
Rose is a rose is a rose? Aerosol therapy in ventilated patients: nebulizers versus metered dose inhalers--a continuing controversy. Am Rev Respir Dis (1993) 1.43
Pulmonary aerosol deposition in chronic bronchitis: intermittent positive pressure breathing versus quiet breathing. Am Rev Respir Dis (1977) 1.43
Reliable salbutamol administration in 6- to 36-month-old children by means of a metered dose inhaler and Aerochamber with mask. Pediatr Pulmonol (1989) 1.40
Use of scintillation camera and 135-xenon for study of topographic pulmonary function. Respir Physiol (1968) 1.39
Community acquired pneumonia. A perspective for general practice. Aust Fam Physician (2000) 1.37
Improvement in airway responsiveness and asthma severity during pregnancy. A prospective study. Am Rev Respir Dis (1989) 1.33
Deposition and fate of aerosolized drugs. Chest (1978) 1.29
Are active and passive smoking harmful? Determining causation. Chest (1985) 1.29
Emergency department management of life-threatening asthma. Are nebulizers obsolete? Chest (1993) 1.27
Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial. Eur Respir J (2002) 1.23
Studies on the pharmacokinetics and pharmacodynamics of atenolol in man. Eur J Clin Pharmacol (1978) 1.22
Aerosol therapy with Sch 1000. Short-term mucociliary clearance in normal and bronchitic subjects and toxicology in normal subjects. Chest (1978) 1.22
Nasal ciliary ultrastructure and function in patients with primary ciliary dyskinesia compared with that in normal subjects and in subjects with various respiratory diseases. Am Rev Respir Dis (1984) 1.17
Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation. Arch Intern Med (1988) 1.16
Response of asthmatic patients to fenoterol inhalation: a method of quantifying the airway bronchodilator dose. Clin Pharmacol Ther (1978) 1.16
Site of beta-adrenergic receptors in the respiratory tract: use of fenoterol administered by two methods. Chest (1978) 1.15
Gastroesophageal reflux and chronic respiratory disease. Am Rev Respir Dis (1984) 1.13
Aerosol penetration into the lung; influence on airway responses. Chest (1981) 1.13
New insights into the role of zinc in the respiratory epithelium. Immunol Cell Biol (2001) 1.12
Effect of chest physiotherapy on the removal of mucus in patients with cystic fibrosis. Am Rev Respir Dis (1982) 1.12
Alveolar macrophage/peripheral blood monocyte-derived factors modulate proliferation of primary lines of human lung fibroblasts. J Leukoc Biol (1987) 1.09
Lung epithelial permeability: relation to nonspecific airway responsiveness. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.09
Thoracoscopy. A safe, accurate diagnostic procedure using the rigid thoracoscope and local anesthesia. Chest (1979) 1.07
The dyskinetic cilia syndrome. Ciliary motility in immotile cilia syndrome. Chest (1980) 1.03
Randomised controlled study of early use of inhaled corticosteroid in preterm infants with respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed (1999) 1.03
Efficiency of aerosol medication delivery from a metered dose inhaler versus jet nebulizer in infants with bronchopulmonary dysplasia. Pediatr Pulmonol (1996) 1.03
Effects of postural drainage, exercise, and cough on mucus clearance in chronic bronchitis. Am Rev Respir Dis (1979) 1.03
Smoking-related beliefs and behaviour among adults with asthma in a representative population sample. Aust N Z J Med (1995) 1.00
Effect of histamine on proliferation of normal human adult lung fibroblasts. Thorax (1988) 1.00
Aerosol delivery to the rabbit lung with an infant ventilator. Pediatr Pulmonol (1986) 0.98
Metered-dose inhaler accessory devices in acute asthma: efficacy and comparison with nebulizers: a literature review. Arch Pediatr Adolesc Med (1997) 0.97
Home care by outreach nursing for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2001) 0.97
Ipratropium bromide (Sch 1000) monohydrate aerosol: bronchodilator effect of three dose levels in asthmatics. Lung (1978) 0.95
Health effects of urea formaldehyde foam insulation: evidence of causation. CMAJ (1986) 0.95
The dyskinetic cilia syndrome; abnormal ciliary motility in association with abnormal ciliary ultrastructure. Chest (1981) 0.95
Effects of exercise and eucapnic hyperventilation on bronchial clearance in man. J Appl Physiol Respir Environ Exerc Physiol (1977) 0.93
Chronic cough and gastroesophageal reflux. CMAJ (1989) 0.93
Primary ciliary dyskinesia: evaluation and management. Pediatr Pulmonol (1988) 0.93
Immotile cilia syndrome in persons with and without Kartagener's syndrome. Am Rev Respir Dis (1980) 0.92
Beclomethasone dipropionate aerosol in allergic rhinitis. Can Med Assoc J (1976) 0.91
Asthma prevalence, morbidity and management practices in South Australia, 1992-1995. Aust N Z J Med (1997) 0.91
Effect of TLV levels of SO2 and H2 SO4 on bronchial clearance in exercising man. Arch Environ Health (1978) 0.91
Pulmonary mucociliary clearance in cystic fibrosis. N Engl J Med (1973) 0.90
Nasal polyposis: in search of a viral etiology using DNA hybridization. J Otolaryngol (1991) 0.89
Inspiratory flow rates through a novel dry powder inhaler (Clickhaler) in pediatric patients with asthma. J Aerosol Med (1999) 0.89
Therapeutic equivalence of three metered-dose inhalers containing salbutamol (Albuterol) in protecting against methacholine-induced bronchoconstriction in children with asthma. Pediatr Pulmonol (2001) 0.89
Quantitation of regional aerosol clearance in the normal human lung. J Appl Physiol (1972) 0.89
Aerosol therapy: nebulizer vs metered dose inhaler. Chest (1987) 0.89
Are nebulizers obsolete for administering asthma medications to infants and children? Pediatr Pulmonol (1993) 0.88
Aerosol therapy with valved holding chambers in young children: importance of the facemask seal. Pediatrics (2001) 0.88
UFFI dust: nonspecific irritant only? Chest (1982) 0.88
Ciliary function, cell viability, and in vitro effect of ribavirin on nasal epithelial cells in acute rhinorrhea. Chest (1992) 0.88
Aerosol therapy of reversible airflow obstruction. Concepts and clinical applications. Chest (1987) 0.87
Control of asthma. Can Med Assoc J (1982) 0.86
Home care by outreach nursing for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2000) 0.86
Effect of add-on devices for aerosol drug delivery: deposition studies and clinical aspects. J Aerosol Med (1996) 0.86
Activation of nasal cilia in immotile cilia syndrome. Am Rev Respir Dis (1979) 0.86
A controlled trial of ambroxol in chronic bronchitis. Chest (1987) 0.86
Dipyridamole - is it a bronchodilator? Eur J Respir Dis (1981) 0.85
Lung deposition and clearance of inhaled (99m)Tc-heparin in healthy volunteers. Am J Respir Crit Care Med (1999) 0.85
The value of the lipid-laden macrophage index in the assessment of aspiration pneumonia. Aust N Z J Med (1997) 0.85
Suction excision biopsy for diffuse pulmonary disease. Chest (1973) 0.84
Evaluation of a new method to create a standardized muscle stretch injury. Med Sci Sports Exerc (1998) 0.84
Dry powder versus intravenous and nebulized gentamicin in cystic fibrosis and bronchiectasis. A pilot study. Am J Respir Crit Care Med (1999) 0.84
Mechanism of bronchodilator effect in chronic airflow limitation. CMAJ (1991) 0.84
Sulfur dioxide and tracheobronchial clearance in man. Arch Environ Health (1975) 0.84
Is theophylline obsolete? Chest (1990) 0.83
Acute exposure of symptomatic steelworkers to sulphur dioxide and carbon dust: effects on mucociliary transport, pulmonary function, and bronchial reactivity. Br J Ind Med (1984) 0.83
Pulmonary deposition of salbutamol aerosol delivered by metered dose inhaler, jet nebulizer, and ultrasonic nebulizer in mechanically ventilated rabbits. Pediatr Res (1997) 0.83
Clinical usefulness of n-of-1 randomized controlled trials in patients with nonreversible chronic airflow limitation. Am Rev Respir Dis (1991) 0.82
Increased effective lung volume following lung volume reduction surgery in emphysema. Chest (2001) 0.82